XENE — Xenon Pharmaceuticals Inc. | XLV Holdings | StockAdder

(XENE)

Xenon Pharmaceuticals Inc.

Live chart and latest XENE stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

XENE News

The Globe and Mail

Xenon Expands 2025 Inducement Equity Incentive Plan

Apr 14, 2026 Stock Titan

Xenon Pharmaceuticals (XENE) boosts 2025 inducement equity plan share reserve

Apr 13, 2026 Investing.com

Xenon Pharmaceuticals stock surges 40% on positive trial data

Mar 9, 2026 marketscreener.com

Certain Stock Options of Xenon Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 10-APR-2026.

Apr 10, 2026 Yahoo Finance

XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study

Mar 10, 2026 Investor's Business Daily

Why This Biotech, Up 47%, Could Spark The Next Buyout Frenzy

Mar 9, 2026 Seeking Alpha

Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked (NASDAQ:XENE)

Mar 9, 2026 Quiver Quantitative

Xenon Pharmaceuticals Inc. Prices Upsized Public Offering, Anticipated Gross Proceeds of Approximately $650 Million

Mar 11, 2026 simplywall.st

Is Xenon Pharmaceuticals (XENE) Pricing Look Compelling After Recent 37% Weekly Share Surge?

Mar 12, 2026 Yahoo Finance

Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward

Mar 15, 2026 Stock Titan

$500M stock sale: neuroscience drug maker Xenon tests market appetite

Mar 9, 2026 Investing.com

Xenon Pharmaceuticals launches $500 million stock offering

Mar 9, 2026 Quiver Quantitative

Xenon Pharmaceuticals to Announce Topline Data from Phase 3 X-TOLE2 Study of Azetukalner for Focal Onset Seizures

Mar 8, 2026 Yahoo Finance

Assessing Xenon Pharmaceuticals (XENE) Valuation After A Sharp Recent Share Price Surge

Mar 12, 2026 Stock Titan

Xenon brings 48-month epilepsy drug data and Phase 3 results to AAN